Biphasic effects of naloxone in the rats receiving morphine overdose a place preference study

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 3, 2011, Pages 605-610

  Karimi, Sara ^a   Karami, Manizheh ^a   Zardooz, Homeira ^b   Salimi, Seyed Hassan ^c   Sahraei, Hedayat ^d  

^a SHAHED UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Conditioned; Locomotion; Morphine; Naloxone; Place preference; Rat; Rearing; Sniffing

Indexed keywords

MORPHINE; NALOXONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PROVOCATION TEST; RAT; REARING; REWARD; SNIFFING; TELEVISION CAMERA;

EID: 84856947656     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Spanagel R and Weiss F. The dopamine hypothesis of reward: past and current status. Trends in Neuroscience (1999) 22: 521-7.
2. Wise RA. Drug-activation of brain reward pathwaysDrug and Alcohol Dependence (1998) 51: 13-22.
3. Johnson SW and North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. (1992) 12: 483-9.
4. Di Chiara G and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. (1988) 85: 5274-8.
5. Pontieri FE, Tanda G and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the «shell» as compared with the «core» of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U S A. (1995) 92: 12304-12308.
6. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addiction Biology (2007) 12: 227-462.
7. Koob GF. Drugs of abuse: Anatomy, pharmacology, and function of reward pathways. Trends Pharmacol. Sci. (1992) 13: 177-84.
8. Kalivas PW, Duffy P and Eberhardt H. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J. Pharmacol. Exp. Ther. (1990) 253: 858-66.
9. Tzschentke TM. Measuring reward with the conditioning place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. (1998) 56: 613-72.
10. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. (1995) 38: 95-137.
11. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. (1999) 375: 13-30.
12. Vindenes V, Pettersen BS, Gottas A, Christiansen NL, Boix F and Morland J. Different Effects on Dopamine Release in Nucleus Accumbens in Mice by the Morphine Metabolites Morphine-6-Glucuronide and Morphine-3-Glucuronide. Basic Clin. Pharmacol. Toxicol. 2009 (InPress).
13. Gutstein HB and Akil H. Opioid analgesics. In: Hardman JG, Limbird LE and Goodman Gilman A. (eds.) Goodman and Gilman's the Pharmacological Basis of Therapeutics. 10th ed. McGraw-Hill, New York (2001) 569-619.
14. Wise, R.A., 2008. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14, 169-183.
15. Karami M, Zarrindast MR, Sepehri H and Sahraei H. Role of nitric oxide in the rat hippocampal CA1 area on morphine-induced conditioned place preference. Eur. J. Pharmacol. (2002) 449: 113-19.
16. Blanchard DC and Blanchard RJ. Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci. Biobehav. Rev. (1990) 23: 981-991.
17. Blanchard RJ, Dulloog L, Kaawaloa N and Nishimura O. Acute cocaine effects on stereotypy and defense: an ethoexperimental approach. Neurosci. Biobehav. Rev. (1998) 23: 179-188.
18. Campbell A, B.R., Cremens C, Teicher MH, Marsh E, NS., K., 1989. Bromocriptine antagonizes behavioral effects of cocaine in the rat. Neuropsychopharm 2, 209-224.
19. Welker WI. Analysisof sniffingof thealbinorat. Behavior (1964) 22: 223-244.
20. Youngentob SL, Mozell MM, Sheehe PR and Hornung DE. A quantitative analysis of sniffing strategies in rats performing odor detection tasks. Physiol. Behav. (1987) 41: 59-69.
21. Tolliver BK and Sharp FR. Suppression of C-fos induction in the nucleus accumbens prevents acquisition but not expression of morphine-conditioned place preference. Eur. J. Neurosci. (2000) 12: 3399-3406.
22. Tsuji M, Matsumiya T, Nagase H, Narita M, andSuzuki T. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice. Life Sci. (2001) 68: 1717-1725.
23. Contarino A, Matthes HW, Koob GF, Kieffer BL and Gold LH. Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. Eur. J. Pharmacol. (2002) 446: 103-109.
24. Herzig VSW. Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats. Neurosci. Lett. (2005) 374: 119-123.
25. Herzig VSW. Repeated-testing of place preference expression for evaluation of anti-craving-drug effects. Amino Acids (2005) 28: 309-317.
26. Powell KJ, Jhamandas A, Olmstead MC, Beninger RJ and Jhamandas K. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J. Pharmacol. Exp. Ther. (2002) 300: 588-596.
27. Salamone JD. The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine. J. Neurosci. Methods (1996) 64: 137-149.
28. Sharma SK, Klee WA and Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. PNAS (1995) 72: 302-336.
29. Yeh YC, Lin TF, Wang CH, Wang YP, Lin CJ and Sun WZ. Effect of combining ultralow-dose naloxone with morphine in intravenous patient-controlled analgesia: the cut-off ratio of naloxone to morphine for antiemesis after gynecologic surgery. J. Formos. Med. Assoc. (2008) 107: 478-484.
30. Abul-Husn NS, Sutak M, Milne B and Jhamandas K. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists. Br. J. Pharmacol. (2007) 151: 877-887.